Point72 Asset Management, L.P. 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:56 pm Sale | 2024-09-30 | 13G | Abeona Therapeutics Inc. ABEO | Point72 Asset Management, L.P. | 888,870 2.000% | -760,870 (-46.12%) | Filing |
| 2024-02-14 4:20 pm Purchase | 2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO | Point72 Asset Management, L.P. | 1,649,740 6.400% | 499,092 (+43.37%) | Filing |
| 2023-02-14 4:20 pm Purchase | 2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO | Point72 Asset Management, L.P. | 1,150,648 7.400% | 189,778 (+19.75%) | Filing |
| 2022-11-09 9:10 pm Purchase | 2022-11-03 | 13G | Abeona Therapeutics Inc. ABEO | Point72 Asset Management, L.P. | 960,870 9.990% | 960,870 (New Position) | Filing |